High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis.
about
Strategies for appropriate antibiotic use in intensive care unitNovel pandemic influenza A (H1N1) and community-associated methicillin-resistant Staphylococcus aureus pneumonia.Cephalosporin-Glycopeptide Combinations for Use against Clinical Methicillin-Resistant Staphylococcus aureus Isolates: Enhanced In vitro Antibacterial Activity.Vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations: study protocol for a phase IIB randomized controlled trial.The role of telavancin in hospital-acquired pneumonia and ventilator-associated pneumonia.Optimization of time to initial vancomycin target trough improves clinical outcomesIdentification of Low-Level Vancomycin Resistance in Staphylococcus aureus in the Era of InformaticsEffects of inappropriate empirical antibiotic therapy on mortality in patients with healthcare-associated methicillin-resistant Staphylococcus aureus bacteremia: a propensity-matched analysisThe safety and efficacy of high versus low vancomycin trough levels in the treatment of patients with infections caused by methicillin-resistant Staphylococcus aureus: a meta-analysisVancomycin 24-Hour Area under the Curve/Minimum Bactericidal Concentration Ratio as a Novel Predictor of Mortality in Methicillin-Resistant Staphylococcus aureus BacteremiaOptimizing the detection of methicillin-resistant Staphylococcus aureus with elevated vancomycin minimum inhibitory concentrations within the susceptible range.Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream InfectionsMulticenter prospective observational study of the comparative efficacy and safety of vancomycin versus teicoplanin in patients with health care-associated methicillin-resistant Staphylococcus aureus bacteremia.Vancomycin loading doses: a systematic review.Ceftaroline fosamil as first-line versus second-line treatment for acute bacterial skin and skin structure infections (ABSSSI) or community-acquired bacterial pneumonia (CABP).Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus.Glycopeptide antibiotics: evolving resistance, pharmacology and adverse event profile.Vancomycin, teicoplanin, daptomycin, and linezolid MIC creep in methicillin-resistant Staphylococcus aureus is associated with clonality.Impact of Time to Appropriate Therapy on Mortality in Patients with Vancomycin-Intermediate Staphylococcus aureus Infection.Dosing strategies to optimize currently available anti-MRSA treatment options (Part 1: IV options).Resistance to Non-glycopeptide Agents in Serious Staphylococcus aureus Infections.Intravenous Vancomycin Dosing in the Elderly: A Focus on Clinical Issues and Practical Application.Impact of Vancomycin MIC on Treatment Outcomes in Invasive Staphylococcus aureus Infections.Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment.Reproducible measurement of vancomycin MICs within the susceptible range in Staphylococcus aureus by a broth microdilution method with a "quasi-continuum" gradient of antibiotic concentrations.High vancomycin MICs predict the development of infective endocarditis in patients with catheter-related bacteraemia due to methicillin-resistant Staphylococcus aureus.Telavancin in the Recent Hospital Acquired and Ventilator Associated Pneumonia (HAP/VAP) 2016 Guidelines.Retrospective analysis of vancomycin treatment outcomes in Chinese paediatric patients with suspected Gram-positive infection.Assessment of Minimum Inhibitory Concentrations of Telavancin by Revised Broth Microdilution Method in Phase 3 Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia Clinical Isolates.Is reduced vancomycin susceptibility a factor associated with poor prognosis in MSSA bacteraemia?Clinical, microbiological, and genetic characteristics of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia in a teaching hospitalCombination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA.The efficacy of platelet-rich plasma gel in MRSA-related surgical wound infection treatment: an experimental study in an animal model.Reduced vancomycin susceptibility in porcine ST9 MRSA isolates.Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant gram-negative bacteria.Successful management of methicillin-resistant Staphylococcus aureus bacteremia complicated with diffuse myelitis.Polymyxin-B immobilized column-direct hemoperfusion for adolescent toxic shock syndrome.Multiple Cross Displacement Amplification Coupled With Nanoparticles-Based Lateral Flow Biosensor for Detection of Staphylococcus aureus and Identification of Methicillin-Resistant S. aureus.Meta-Analysis: Vancomycin Treatment Failures for MRSA Bacteremia Based on MIC Determined by E-test.
P2860
Q27002517-30D74B71-2DEF-4911-A2D3-AE4E137C0B03Q30370676-B05DE4B2-313C-4707-A301-8FF9BC7F4E22Q33700986-EF4A424C-81A7-42A7-AD4E-03E6BF840F3CQ33844670-3C4C32AA-7694-46F8-B5D8-09C77D05054FQ34672655-CDD157C6-FFE0-4D07-9AD0-28B406D85F38Q35862844-B5C2DE1E-A090-4197-AB4E-C6AE6DF23E0CQ35920382-2AF33E64-49B7-47D0-8994-933003658020Q36078305-9B8B1623-0D86-4AC1-8163-4EF46E9F70D5Q36148828-6EA154C5-CACB-4A72-B4FE-7E5F1B534767Q36888003-743DF967-E624-4071-B8EF-313AB763DF66Q36981191-EE0ED6FF-D45E-4ED6-AD82-4F07CE021D69Q37287739-E687508D-55B4-40AA-A0E3-491ED191EDD2Q37544314-ECA39342-068A-442E-AC69-82CC79C7D452Q38364909-04A77239-2A42-4A39-9C05-2C1B1A5AD8BCQ38394008-C39FCF99-2EB8-4A79-A986-1C5BE10AF81DQ38425879-DF837218-0173-45DA-9462-630338712379Q38545589-66DEB2F1-4D73-4012-84AF-B31A1EAD271DQ38811664-552F87F0-09F1-4A63-A894-5A060DA73009Q38843037-B8C80CF4-772E-4C83-BA29-A890FF83999AQ38907793-B31EFE3E-62F6-4F14-940B-4179CEE120E7Q39016281-2CEDB9C9-6065-438E-961C-BFBA3B23BC04Q39017701-FCDD2ABD-61ED-4454-A4FF-1FC0B4B83552Q39107373-22D91416-B0CB-4AD7-AB9F-9F899F4C1993Q40083539-3702D908-CF25-4BC9-94AD-7D8876300D7BQ40121177-25FA0535-15D3-4DF5-A328-F5B5846AECADQ40263706-773DB87B-EB01-40B3-A720-752E8530F049Q40267844-BD967B22-FAFC-486A-B3AC-FF222F04754AQ40483780-546E2D4A-3F27-43B4-8393-27EE18C4358FQ40513210-05F8779B-BCBE-456C-921E-0A6094248FE4Q40891194-B4C1630D-761C-4949-A22C-300DF8F20A5FQ41584600-49254385-9E3B-4F97-855F-A8CB890C1DDDQ41869403-879DF756-BB08-4F3B-850E-5881B54BA56EQ41992606-31B5E29F-EEF9-4F09-8B43-D1CFE4684AC4Q42905367-1C03E4FA-E0C7-4B44-9872-663E857A7030Q44160090-1E196ACA-B2AA-4915-8A2A-9E4E28938F72Q44250798-6A37BE94-F21F-4728-A6CA-9809CEB27C60Q51349847-02E8003D-2918-4049-8595-116420496E7EQ55117916-EE4DB123-23A4-4F10-AB95-07CE262D1F9BQ55194542-706582B8-13E3-4800-8463-E197CF816BB2
P2860
High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
High vancomycin minimum inhibi ...... s infections: a meta-analysis.
@ast
High vancomycin minimum inhibi ...... s infections: a meta-analysis.
@en
High vancomycin minimum inhibi ...... s infections: a meta-analysis.
@nl
type
label
High vancomycin minimum inhibi ...... s infections: a meta-analysis.
@ast
High vancomycin minimum inhibi ...... s infections: a meta-analysis.
@en
High vancomycin minimum inhibi ...... s infections: a meta-analysis.
@nl
prefLabel
High vancomycin minimum inhibi ...... s infections: a meta-analysis.
@ast
High vancomycin minimum inhibi ...... s infections: a meta-analysis.
@en
High vancomycin minimum inhibi ...... s infections: a meta-analysis.
@nl
P2860
P1476
High vancomycin minimum inhibi ...... s infections: a meta-analysis.
@en
P2093
Carlos A DiazGranados
Jesse T Jacob
P2860
P304
P356
10.1016/J.IJID.2012.08.005
P577
2012-10-22T00:00:00Z